These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 5755333

  • 21. Cyclophosphamide and vinblastine sulfate in Hodgkin's disease during pregnancy.
    Lacher MJ, Geller W.
    JAMA; 1966 Feb 07; 195(6):486-8. PubMed ID: 5951840
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical experiences with the cytostatic drug natulan].
    Kohout J.
    Med Klin; 1969 May 09; 64(19):898-901. PubMed ID: 5819002
    [No Abstract] [Full Text] [Related]

  • 23. Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).
    Hindy I, Sellei C, Eckhardt S, Szentklãray J, Hartai F.
    Neoplasma; 1971 May 09; 18(3):277-82. PubMed ID: 4937513
    [No Abstract] [Full Text] [Related]

  • 24. Chemotherapy of neoplasia (cancer) with dehydroemetine.
    Abd-Rabbo H.
    J Trop Med Hyg; 1969 Dec 09; 72(12):287-90. PubMed ID: 5272222
    [No Abstract] [Full Text] [Related]

  • 25. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG, Chandra A, Raman SG.
    Med Pediatr Oncol; 2003 Jan 09; 40(1):66-9. PubMed ID: 12426693
    [No Abstract] [Full Text] [Related]

  • 26. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE, Peterson BA, Kennedy BJ, Vosika G, Bloomfield CD.
    Arch Intern Med; 1981 Jun 09; 141(7):897-900. PubMed ID: 7235809
    [Abstract] [Full Text] [Related]

  • 27. [Differing sensitivity to cytostatic drugs in superficial and deep groups of lymph nodes].
    Aggio MC, Alvarez RV, Rocca EO, Bouzat J.
    Sangre (Barc); 1970 Jun 09; 15(3):379-82. PubMed ID: 5486765
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of genital cancers with polychemotherapy. Contribution to their study].
    Sonkin R, Coudeyras M, Blondon J.
    J Gynecol Obstet Biol Reprod (Paris); 1972 Jun 09; 1(1):61-9. PubMed ID: 5038021
    [No Abstract] [Full Text] [Related]

  • 29. Breast involvement in nodular lymphocyte predominant type Hodgkin lymphoma in childhood.
    Aksu G, Inan N, Corapcioglu F, Tugay M, Anik YA.
    Pediatr Hematol Oncol; 2008 Mar 09; 25(2):159-61. PubMed ID: 18363184
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E.
    Ann Acad Med Stetin; 1996 Mar 09; 42():105-22. PubMed ID: 9199116
    [Abstract] [Full Text] [Related]

  • 31. [Hodgkin's disease].
    G Clin Med; 1968 Jan 09; 49(1):112-5. PubMed ID: 5736616
    [No Abstract] [Full Text] [Related]

  • 32. High-dose chemotherapy with stem cell rescue for solid tumours.
    Protheroe AS, Johnson PW.
    Br J Hosp Med; 1968 Jan 09; 55(7):437-41. PubMed ID: 8730570
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of hematopoietic proliferative syndromes with a semi-synthetic podophyllin derivative].
    Lawkowicz W, Krzemińska-Lawkowiczowa, Polubiec A, Kolakowska-Polubiec K, Domańska B, Kolakowski L.
    Acta Haematol Pol; 1973 Jan 09; 4(2):123-7. PubMed ID: 4740783
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ, Zimmerman T, Meyers S, Bender JG, Williams SF.
    Prog Clin Biol Res; 1994 Jan 09; 389():421-7. PubMed ID: 7535451
    [No Abstract] [Full Text] [Related]

  • 35. [Natural substances with carcinostatic properties].
    Strauch R, Hiller K.
    Pharmazie; 1974 Jan 09; 29(10-11):656-70. PubMed ID: 4612561
    [No Abstract] [Full Text] [Related]

  • 36. [Therapy of lymphogranuloma].
    Hennemann HH.
    Minerva Med; 1970 May 12; 61(38):2097-9. PubMed ID: 5420339
    [No Abstract] [Full Text] [Related]

  • 37. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7555-64. PubMed ID: 16234521
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients.
    Veneri D, Zanetti F, Franchini M, Krampera M, Pizzolo G.
    Haematologica; 2002 Nov 20; 87(11):ELT43. PubMed ID: 12414364
    [No Abstract] [Full Text] [Related]

  • 40. Changes of oxyindole acetic acid excretion and the thrombocyte count under the influence of Zitofenton.
    Masszi F, Máté-Wójcińska U.
    Neoplasma; 1965 Nov 20; 12(6):629-33. PubMed ID: 5324521
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.